Bioheterocycles 2019

XVIII International Conference on Heterocycles in Bioorganic Chemistry

 Ghent, Belgium    June 17-20, 2019

Biotage is a global leader in life science technology. With a broad scope of tools for synthesis, work-up, purification, evaporation and analysis, the company provides solutions, knowledge and expertise in the areas of peptide synthesis, analytical chemistry, medicinal chemistry, and process-development. Our focus is on developing technology to speed experimental procedures.

Laboratory Supplier for Organics, Heterocycles, Fluorochemicals, Biochemicals, Precious Metal Compounds, Catalysts, high pure Inorganics and Metals - also representing Fluorochem, BLD Pharm, Glentham Life Sciences, Key Organics, Menai Organics and J&W Pharmlab.

A competitive chemical supplier of reagent and building blocks for research and development to the pharmaceutical companies, universities and those performing contract research. Home of the new search facility “Doug Discovery”. Come and ask for a demo alternatively check it out yourself at www.dougdiscovery.com.

Iris Biotech specializes in reagents for Drug Discovery, Drug Delivery, and Diagnostics. We have know-how and production capabilities to manufacture and supply products for following areas:
1. Starting Materials for Peptide Synthesis, Peptidomimetics and Medicinal Chemistry.
2. Technologies for Drug Delivery.Worldwide largest portofolio of PEGylation reagents, selection of certain Poly(amino acids). Different ADC linkers.
3. Reagents for Life Sciences and Diagnostics.

Mestrelab specializes in the development of software for the processing and analysis of Chemical information. Our main product Mnova is a multiplatform (Windows, Mac, Linux) and multivendor software designed for combined NMR/LC/GC/MS/UV/IR/Raman techniques. Our new product Mbook, is an ELN designed for the chemist.

Founded in 2015 as a spin-out from Vironova AB, Vironova Medical AB is developing antiviral compounds against herpes and influenza virus. In our portfolio we have patented antiviral molecules with a novel mode of action. In addition, we also have a chemical process technology for thionation of compounds used in pharmaceuticals. Thionating drug molecules can alter characteristics such as bioavailability and result in more potent and selective compounds.